Walter Greenblatt & Associates | Return Home

Building the Bridge from Inception to Exit

  • Company Inception
  • Proof of Concept (in Vivo/Human)
  • Development
  • Growth
  • Exit (IPO/M&A or Partnership)
  • Commercial Success
  • Company Inception
  • $1-4M Seed Funding In Vivo Proof of Concept
  • $5-20M First Institutional Funding—Human Proof of Concept
  • $20-100M Follow on Euqity Rounds to Fund Clinical Trials
  • Exit (IPO/M&A or Partnership)
  • Commercial Success
  • Company Inception
  • $1-5M Seed Funding In Vivo Proof of Concept
  • $5-20M First Institutional Funding—Human Proof of Concept: Regulatory Clearance; Commerical Launch
  • $10-40M Follow on Equity Rounds to Fund Commercialization / market penetration
  • Exit (IPO/M&A or Partnership)
  • Commercial Success
  • Company Inception
  • $1-5M Seed Funding Commercial Proof of Concept
  • $5-20M First Institutional Funding—Build Infrastructure; Add Major Customers
  • $20-40M Follow on Equity Rounds to Fund Commercialization/market penetration
  • Exit (IPO/M&A)
  • Commercial Success
Angel / Seed Round Commercialization Round Growth Round Exit / Liquidity Commercial Success
WuXi PharmaTech NYSE:WX (Shanghai)
Raised $2.2M Angel Round 2003/4
Raised $19.2M VC Round 2005
Raised $50M pre-IPO Series C Round (Institutional) IPO on NYSE Aug 2007 NYSE: WX 2007 Annual Revenues $500M; NYSE Listed: Market Cap $2.7B (as of January 2014)
Advanced BioHealing (San Diego)
Raised $2.4M Angel Round 2004
Raised $8.0M VC Round 2005
Acquired Marketed Products from Smith & Nephew 2006
Sold to Shire Pharmaceutical for $750M in cash in 2011 Q2 Annual Revenues $250M
QuantumBio (State College, PA)
In-Licensed PSU Technology; Raised $250K from BFTP 2002/3
Raised $1.1M Life Science Greenhouse/ Angel Round 2003
Raised more than $5.5M SBIR/STTR Grants since 2004
MedAvante (Princeton, NJ)
Raised $6.7M Hybrid Angel/ VC Round 2007
Raised $20.0M VC Round 2008
Growing service revenues rapidly since 2009    
Callidus BioPharma (Doylestown, PA)
Raised $1.1M Hybrid Angel/ VC round 2012
Raised $3.5M Hybrid Angel/VC round 2013
  Sold to Amicus Therapeutics for $15M in cash plus up to $115M milestones in 2013 Q4  
Core Essence Orthopaedics (Ft.Washington, PA)
Raised $2.9M Angel Round 2010
Raised $5.2M VC Round 2011
Doubled seven figure product revenues in 2011 v. 2010    
Walter Greenblatt & Associations Transaction
Follow-ons completed by company affiliates or others